| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.56B | — | +7.6% |
| Cost of Revenue | $886.3M | — | +6.7% |
| R&D Expense | $84.6M | — | +13.9% |
| SG&A Expense | $237.4M | — | +1.5% |
| Operating Income | $294.2M | — | +13.5% |
| Pre-tax Income | $278.7M | — | +16.7% |
| Income Tax | $51.9M | — | +3.6% |
| Net Income | $226.8M | — | +20.3% |
| EPS (Basic) | $4.90 | — | +21.6% |
| EPS (Diluted) | $4.85 | — | +21.6% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $521.4M | +48.0% | +13.0% |
| Accounts Receivable | $969.2M | -2.3% | +3.6% |
| Inventory | $1.12B | +7.5% | +10.9% |
| Current Assets | $3.32B | +8.8% | +11.4% |
| Total Assets | $15.49B | +1.4% | +3.0% |
| Current Liabilities | $1.89B | +1.7% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $234.0M | — | -3.5% |
| Capital Expenditures | $29.7M | — | +65.0% |
| Investing Cash Flow | -$83.1M | — | +89.3% |
| Financing Cash Flow | $18.4M | — | -94.6% |
| Free Cash Flow | $204.3M | — | -9.0% |
| +38.7% |
| Long-term Debt | $2.48B | +0.0% | -16.5% |
| Total Liabilities | $4.79B | +0.4% | -6.4% |
| Stockholders' Equity | $10.70B | +1.8% | +7.9% |